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0022-2836© 2009 Elsevier Ltd. Open acceEngineered receptor fragments and glycoprotein ligands employed in
different assay formats have been used to dissect the basis for the dramatic
enhancement of binding of two model membrane receptors, dendritic cell-
specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)
and the macrophage galactose lectin, to glycoprotein ligands compared to
simple sugars. These approaches make it possible to quantify the importance
of two major factors that combine to enhance the affinity of single
carbohydrate-recognition domains (CRDs) for glycoprotein ligands by 100-
to 300-fold. First, the presence of extended binding sites within a single CRD
can enhance interaction with branched glycans, resulting in increases of
fivefold to 20-fold in affinity. Second, presentation of glycans on aglycoprotein
surface increases affinity by 15-to 20-fold, possibly due to low-specificity
interactionswith the surface of the protein or restriction in the conformation of
the glycans. In contrast, when solution-phase networking is avoided,
enhancement due to binding of multiple branches of a glycan to multiple
CRDs in the oligomeric forms of these receptors is minimal and binding of a
receptor oligomer to multiple glycans on a single glycoprotein makes only a
twofold contribution to overall affinity. Thus, in these cases, multivalent
interactions of individual glycoproteins with individual receptor oligomers
have a limited role in achieving high affinity. These findings, combined with
considerations of membrane receptor geometry, are consistent with the idea
that further enhancement of the binding to multivalent glycoprotein ligands
requires interaction of multiple receptor oligomers with the ligands.© 2009 Elsevier Ltd. Open access under CC BY license. Edited by I. Wilson Keywords: glycan-binding receptors; lectins; glycoproteins; affinityess:
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Receptor-mediated binding of sugars underpins
recognition events important for cell–cell adhesion,
serum glycoprotein clearance, innate immune rec-
ognition of pathogens and other biological pro-
cesses.1-4 Such glycan-mediated binding events in
solution and at cell surfaces typically involve multi-
meric glycan-binding receptors, also known as
lectins, interacting with glycoproteins bearing mul-
tiple oligosaccharides. The importance of multi-
valency in the interaction of glycans with receptors
is widely documented for glycan-binding molecules
of diverse bacterial, plant and animal origin.5-8
Levels of enhancement of ligand binding resulting
from multivalency have reached 106-fold in some
686 High Affinity Glycoprotein–Receptor Bindingassay conditions.5,9,10 For the C-type animal lectins, a
diverse group of glycan-binding receptors contain-
ing carbohydrate-recognition domains (CRDs) that
share a Ca2+-dependent mechanism of interaction
with monosaccharide residues, the fundamental
binding interaction is typically very weak, with
dissociation constants of the order of 1 mM.11-13 A
number of different factors have been invoked to
explain how affinity and specificity of glycan-
binding receptors containing C-type CRDs can be
increased to achieve biologically relevant interac-
tions (Fig. 1). In spite of the high levels of affinity
enhancement reported for earlier studies, the con-
tributions of these individual factors have often been
difficult to dissect and some affinity enhancements
have been measured under conditions that would
not be relevant to the natural biological situation. For
example, the three-dimensional network arrange-
ment seen for soluble lectins14 (Fig. 1i) would not
generally be possible for membrane-resident glycan-
binding receptors.
New experimental approaches to measuring bind-
ing interactions have facilitated exploration of some
of the sources of affinity in greater detail. ForFig. 1. Potential sources of enhanced affinities in glyco
attachment of multiple glycans to a glycoprotein increases the
binding site interactions can accommodate secondary contact w
elaborations on individual branches. (d) Direct protein–protein
the protein portion of the glycoprotein. (e) The presence of
secondary interactions. (f) and (g), Multiple terminal residu
glycoprotein can interact with multiple CRDs in a receptor olig
interact with glycans on multiple glycoprotein ligands. (i) In s
ligands with oligomeric lectins. CRDs are shown diagrammat
cylinders. A galactose-binding receptor is shown for illustratiexample, the importance of ligand mobility for
interaction with multiple CRDs has been studied
recently using surface-force measurements of the
receptor dendritic cell cell-specific intercellular ad-
hesion molecule 3-grabbing nonintegrin (DC-SIGN),
which is a tetramer that binds to high-mannose
oligosaccharides such as those found on viral
pathogens, including human immunodeficiency
virus.13,15,16 The results demonstrate that conforma-
tional flexibility in the dispositions of CRDs in this
tetrameric receptor observed in structural ana-
lysis17,18 makes interactions of a single oligomer
with multiple glycans possible. Such interactions,
combinedwith ligandmobility, would facilitate two-
dimensional lattice formation (Fig. 1h). A further
recent development is the ability to engineer both
receptors and their glycoprotein ligands. In the case
of DC-SIGN, the ability to express isolated mono-
meric CRDs and tetrameric extracellular domains of
the receptor allows comparison of the effects of CRD
clusters.13 Using this approach, it has been possible
to demonstrate that the CRD of DC-SIGN shows
tenfold higher affinity for a branched glycan than for
mannose, demonstrating the importance of interac-protein-receptor interactions. (a) Glycan branching and
number of terminal sugar residues. (b) and (c) Extended
ith branches on multi-antennary glycans or with terminal
interactions can occur between a CRD and the surface of
multiple glycans on a glycoprotein ligand can lead to
es on one glycan or on different glycans attached to a
omer. (h) On cell surfaces, CRDs in receptor oligomers can
olution, lattices can form from interactions of multivalent
ically as spheres and glycoprotein ligands are indicated as
on purposes.
687High Affinity Glycoprotein–Receptor Bindingtions of a single CRD with multiple branches of a
single glycan (Fig 1b). Structural analysis has shown
that this enhanced affinity results from an extended
binding site on the surface of the CRD, allowing
interaction with the branched oligosaccharide
structure.19 The possibility of producing engineered
glycoproteins as ligands for receptors has been less
exploited to date. Also, very few measurements of
single glycan–CRD interactions have been reported,
in part because these do not fall into an affinity range
that is easily assayed, but label-free methods such as
surface plasmon resonance have the potential to
address this gap.
In the current studies, the behavior of isolated
CRDs and CRDs clustered in naturally occurring
oligomers have been compared in parallel condi-
tions, using engineered glycoprotein ligands pre-
senting different numbers of glycans on a common
backbone in multiple assay formats. The results
using DC-SIGN and the structurally and function-
ally divergent macrophage galactose lectin as model
receptors reveal that affinity enhancements for
binding of glycoprotein ligands of greater than
1000-fold can result from the combined effects of
presentation on a protein surface and the presence of
extended binding sites in the receptor CRDs.Fig. 2. Determination of the affinity of DC-SIGN for glyco
monomeric CRD to immobilized SBA and glycopeptide deriv
curves with a linear increase in nonspecific background bin
glycopeptide from SBA to immobilized CRD from DC-SIGN. K
(d) Binding competition assays in which immobilized CRD fro
the presence of competing ligands. Data were fit to simple firResults
Using DC-SIGN to assess affinity enhancement
resulting from glycan presentation on proteins
In initial studies, DC-SIGN was used to demon-
strate the importance of some potential factors in
enhancing glycoprotein binding to a CRD and to
validate appropriate assay formats. The availability
of a highly soluble, monomeric CRD from DC-SIGN
and the fact that high-mannose oligosaccharides
bind to this receptor with affinities that fall within
the range that can be determined using surface
plasmon resonance provided an opportunity to
measure the interaction directly. Making use of the
fact that each subunit of soybean agglutinin (SBA)
bears a single, uniform Man9GlcNAc2 oligosac-
charide,20 N-hydroxysuccinimide chemistry was
used to prepare surfaces coated with the intact
glycoprotein and with the glycopeptide isolated
from it, in order to assess the effect of glycan
presentation on a protein backbone (Fig. 1d). Effects
of valency were eliminated by analyzing the
interaction with monomeric CRDs. Because of the
rapid rates of association and dissociation, interac-peptide and glycoprotein ligands. (a) and (b) Binding of
ed from SBA. Data were fit to simple first-order binding
ding to derive dissociation constants. (c) Binding of the
D was derived from fitting as in the previous experiments.
m DC-SIGNwas probed with 125I-labeled mannose-BSA in
st-order competition curves to derive KI values.
Fig. 3. Binding competition assays comparing binding of
a tri-antennary glycopeptide to MGL. Binding curves for
monomeric CRD are shown in blue and curves for trimeric
extracellular domain are shown in red. The KI values
obtained from these experiments are summarized in Table 2.
688 High Affinity Glycoprotein–Receptor Bindingtions were measured under steady-state conditions
and analyzed by fitting the data to a simple
saturation binding model (Fig. 2a and b). The results
suggest that presentation of the oligosaccharide on a
glycoprotein results in a roughly 15-fold enhance-
ment of the binding affinity. However, the data for
the glycopeptide binding experiment fall mostly
below the apparent KD obtained from fitting the
curve, because of limits on the protein concentration
that could be achieved. A more definitive result was
obtained by immobilizing the CRD, because higher
concentrations of glycopeptide could be achieved in
the fluid phase (Fig. 2c). The measured KD of 76 μM
suggests that the enhancement resulting from
presentation of the Man9GlcNAc2 oligosaccharide
on a protein scaffold is closer to 20-fold.
The same interactions were compared in a binding
competition assay, in which the CRD was immobi-
lized on a polystyrene surface and competition for
binding to an iodinated mannose–BSA reporter
ligand was measured (Fig. 2d). These experiments
were done with concentrations of reporter ligand at
least tenfold below the KD value for the reporter
ligand, in a region where bound ligand is linearly
proportional to input ligand concentration. Under
such conditions, the KI values for the competing
ligands closely approximate their KD values.21 The
ratio of KI,mannose to KI,glycopeptide is 51 (3.5 mM/
68 μM), which indicates that DC-SIGN binds to a
Man9GlcNAc2 glycopeptide with more than 50-fold
higher affinity than it binds tomannose. On the basis
of the presence of three terminal mannose residues,
the affinity for the glycopeptide would be expected
to be only threefold higher than the affinity for
mannose, so the actual affinity ratio is roughly 51/3,
which is 17-fold higher thanwould be expected. This
value is consistent with previous studies and can be
explained on the basis of the enhanced affinity for the
branched mannose structure that has been observed
to interact with an extended binding site in the
CRD.22,23 The ratio of the affinities for the glycopep-
tide and the intact soybean agglutinin (KI,glycopeptide/
KI,SBA= 68 μM/2.4 μM) suggests a further enhance-
ment of 28-fold for binding to the glycoprotein
compared to the glycopeptide.
The absolute values of the affinities measured in
the competition assay and the enhancement result-
ing from presentation of the oligosaccharide on a
protein scaffold are remarkably consistent with the
values from the direct binding analysis, considering
the widely different assay formats involved. This
result suggests that the competition assay also
measures largely a single glycan–CRD interaction.
For the free glycopeptide, this is expected, but it
might seem more surprising for the intact glycopro-
tein, which is tetrameric. However, the multiple
glycans on the tetramer are apparently not well
disposed for binding to the CRDs exposed on a
surface. Only two glycans are presented on each face
of the soybean agglutinin tetramer,24 and the close
spacing of these glycans relative to the size of a CRD,
as well as the precise orientation required to
accommodate the oligosaccharide in the extendedbinding site on the CRD, apparently make it difficult
to align more than one glycan for high-affinity
binding to CRDs immobilized on a plastic surface
and there is minimal enhancement in affinity. The
consistency of the results in these different assay
formats validates the competition assay as a way to
compare affinities, which allows analysis of other
receptor systems where the surface plasmon reso-
nance approach is not applicable.
Comparing the affinity of the CRD from DC-SIGN
for mannose as measured in the competition assay
(KI= 3.5 mM; Fig. 2d) with the most conservative
value for the CRD–glycoprotein interaction that
comes from the surface plasmon resonance experi-
ment (KD= 4.0 μM; Fig. 2a), the ratio of affinities is
875. This affinity is nearly 300-fold higher than the
threefold enhancement that would be expected based
on the presence of three terminal mannose residues
per soybean agglutinin polypeptide. This nearly 300-
fold increase in affinity results from combined
enhancements of 15-to 20-fold each from the presence
of an extended binding site for the oligosaccharide
ligand and presentation of glycans on a protein,
without any need to invoke multivalent binding.
Effect of glycan branching on binding to a
galactose-specific receptor
In order to demonstrate that the enhancement
effects for individual C-type CRDs interacting with
branched glycans presented on proteins represent a
general phenomenon, it was of interest to examine
another oligomeric receptor with substantially
different organization and ligand-binding specifici-
ty. Oligomeric membrane-bound, glycan-binding
receptors with C-type CRDs fall into two divergent
groups on the basis of their primary binding
specificity for mannose and related monosacchar-
ides or galactose and related monosaccharides.25
While DC-SIGN falls in the mannose-binding group,
the macrophage galactose lectin (MGL) is a repre-
sentative galactose-binding receptor that in rat and
Table 1. Inhibition constants for asialofetuin glycopeptide binding to MGL
CRD ECD
KI (μM) 260±20 160±45
KGal/KI 21.5 35
Enhancement due to CRD affinity for branched glycans (fold) 7.2×
Enhancement due to ECD affinity for branched glycans (fold) 11.7×
Enhancement due to multiple CRDs binding branches (fold) 1.6×
Binding inhibition experiments were done on plates coated with the CRD or ECD portions of MGL using 125I-labeled Gal-BSA as the
reporter ligand.
689High Affinity Glycoprotein–Receptor Bindinghumans consists of a single type of subunit,26,27 and
is able to bind to viral glycoproteins, such as those
on Ebola and other filoviruses.28 MGL is homolo-
gous to the hepatic asialoglycoprotein receptor and
the sequence of the neck that links the CRDs to the
membrane anchor is consistent with the presence of
a potential coiled-coil domain that would stabilize
an oligomeric structure like the trimer formed by the
major subunit of the hepatic receptor.29 Chemical
crosslinking and gel-filtration analysis confirmed
that the extracellular domain of MGL expressed in
bacteria forms trimers (Supplementary Data Fig. 1).
The effect of glycan branching on interaction with
MGL was investigated by probing both monomeric
CRDs and trimeric extracellular domains of MGL
with a desialylated tri-antennary glycopeptide,
isolated from fetuin, in the competition bindingFig. 4. Creation and characterization of glycosylation varia
with 1 to 4 glycosylation sites. (e) SDS-PAGE of a selection of
chromatography on immobilized nickel columns were visualiz
model was created with InsightII and Molscript56 based on thassay (Fig. 3). The relative affinity of the CRD for the
glycopeptide compared to galactose is 21.5 (Table 1),
which is 7.2-fold higher than the expected threefold
enhancement that would be expected based solely
on the presence of three terminal galactose residues.
This roughly sevenfold enhanced affinity for
branched glycans is somewhat like that observed
for DC-SIGN (illustrated in Fig. 1b). Binding to the
trimeric extracellular domain was enhanced a
further 1.6-fold (Table 1), suggesting that binding
of multiple terminal sugars by multiple CRDs in the
extracellular domain (illustrated in Fig. 1f) makes
only a small contribution to the overall affinity of the
intact receptor for a branched glycan. The effect of
branching on binding to MGL is consistent with
previous results from testing this protein against a
glycan array, because several of the ligands givingnts of orosomucoid. (a)–(d) Modeled structures of mutants
glycosylation variants. Glycoproteins purified by affinity
ed on the gel by staining with Coomassie brilliant blue. The
e structure of bovine lactoglobulin (PDB ID 1B8E).57
Table 2. Distribution of N-linked glycans on variant asialo-orosomucoid molecules
Variant Bi-antennary (%) Tri-antennary (%) Tetra-antennary (%) Terminal galactose residues
1a 45 51 3 2.6
1b 67 30 2 2.3
1c 89 11 1 2.2
Average for single-site variants 2.4
2a 25 59 16 5.8
2b 47 47 5 5.1
2c 45 36 19 5.5
2d 32 53 16 5.8
2e 37 43 21 5.8
2f 40 40 20 5.6
Average for two-site variants 5.6
3 36 43 21 8.6
4 35 39 26 11.6
5 33 42 26 14.8
Serum-deriveda 14 38 48 16.7
a Values from Ref. [33].
690 High Affinity Glycoprotein–Receptor Bindingthe highest signals for MGL are branched structures
terminating in galactose,30 as well as quantitative
binding assays with linear and branched sugar
structures.31,32 However, the present results dem-
onstrate that, as in the case of DC-SIGN, this
enhancement results primarily from multiple inter-
actions within a CRD and that only a limited further
enhancement results from simultaneous interactions
with multiple CRDs in a receptor oligomer.
Effect of protein presentation on binding to MGL
To facilitate analysis of the additional factors that
contribute to the affinity of MGL for glycoprotein
ligands, variant forms of orosomucoid, a monomeric
serum glycoprotein also known as α1-acid glycopro-
tein, that bear differing numbers of glycans were
developed. Human orosomucoid contains five sites
forN-linked glycosylation, each ofwhich is occupied
by a complex oligosaccharide (Fig. 4).33 Site-directed
mutagenesis was used to generate vectors for the
expression of modified forms of histidine-tagged
orosomucoidwith one to five glycosylation sites. The
proteins were produced in Chinese hamster ovary
cells, purified by affinity chromatography on chelat-
ed nickel columns, and treated with neuraminidase
to remove terminal sialic acid residues. A selection ofFig. 5. Competition experiments to quantify binding of or
ligands with a range of affinities are shown, with measured dthe desialylated glycoproteins separated by SDS-
PAGE is shown in Fig. 4e. The differences in the
mobilities of the proteins in the gel confirmed that
selected glycosylation sites were missing, but that
the remaining glycosylation sites are fully occupied.
The multiple bands for each protein reflect the
presence of different glycoforms of each variant.
The glycans attached to the engineered forms of
orosomucoid were characterized by single and tan-
demmass spectrometry (SupplementaryData Figs. 2
and 3) and compared in a semi-quantitative manner
(Table 2).34 The results confirm that the sialic acid
residues have been removed efficiently and indicate
that each of the glycoproteins bears a mixture of bi-,
tri-, and tetra-antennary complex glycans. Compar-
ing the single-site variants reveals that the position of
glycosylation does affect the degree of branching
and this effect is carried over into the proteins with
multiple glycosylation sites. However, there is no
simple correlation between position or number of
glycosylation sites and the extent of branching.
The glycoprotein presentation effect was investi-
gated using the engineered glycoprotein ligands
containing only a single glycosylation site as well as
a glycopeptide pool from one of the variants. The
results, illustrated in Fig. 5 and summarized in Table
3, reveal that the affinity of MGL for the three singlyosomucoid variants to the CRD from MGL. Examples of
ata shown as circles and fitted curves indicated as lines.
Table 3. Inhibition constants for binding to MGL
Ligand
CRD ECD
KI,ligand
(μM) KI,Gal/KI,ligand
KI,Gal/KI,ligand
per terminal Gal
KI,ligand
(μM) KI,Gal/KI,ligand
KI,Gal/KI,ligand
per terminal Gal
Galactose 5600±150
OR-1b glycopeptide 450±10 12.4 5.1
OR-1a 31±2 34±1
OR-1b 20±6 20±2
OR-1c 17±3 20±1
Average 23±6 243 101 25±7 224 93
OR-2a 4.7 3.1
OR-2b 13 7.5
OR-2c 11 2.1
OR-2d 10 5.0
OR-2e 2.3 8.5
OR-2f 6.4 2.5
Average 8±4 700 125 4.8±2.5 1170 209
OR-3 6.5 930 110 1.5 3700 434
OR-4 3.6 1550 134 0.9 6200 540
OR-5 1.4±0.1 4000 270 0.65±0.12 8615 582
Serum-derived OR 0.12±0.01 31,000 1850 0.18±0.02 47,000 2800
Binding inhibition experiments were done on plates coated with the CRD or ECD portions of MGL, using 125I-labeled Gal-BSA as the
reporter ligand.
691High Affinity Glycoprotein–Receptor Bindingglycosylated variants of orosomucoid varies by a
factor of less than 2, in spite of a range of nearly
fivefold in the relative proportions of bi-and tri-
antennary glycans attached to these variants. These
results suggest that there is relatively little difference
in the affinity of the receptor for the bi-and tri-
antennary oligosaccharides. However, the relative
affinity of the CRD of MGL for the glycopeptide
from variant OR-1b (KI,Gal/KI,glycopeptide= 12.4;
Table 3) is roughly fivefold higher than the 2.3-fold
enhancement that would be expected based on the
presence of an average of 2.3 terminal galactose
residues per glycopeptide. This number is almost as
high as the sevenfold enhancement observed for the
tri-antennary glycopeptide from asialofetuin (TableFig. 6. Summary of the sources of enhanced affinity for gly
linked by the fold enhancement resulting from various factor1), confirming that the degree of branching makes
only a modest contribution to enhanced affinity. The
most striking comparison is the difference in
affinities for the intact glycoproteins bearing a single
glycan (KI= 23 μM; Table 3) and the isolated
glycopeptide derived from one of these glycoprotein
(OR-1b, KI= 450 μM; Table 3), which reveals a 20-
fold enhancement in affinity resulting from presen-
tation of the glycoprotein rather than the glycopep-
tide. Thus, for a glycoprotein bearing a single glycan
interacting with a single CRD, there is a 100-fold
enhancement in affinity even when normalized to
the number of terminal galactose residues present,
resulting from the fivefold effect of the affinity of the
CRD for branched glycans and the 20-fold effect ofcoproteins binding to MGL. The KI values from Table 3 are
s. Letters in parentheses refer to the illustrations in Fig. 1.
692 High Affinity Glycoprotein–Receptor Bindingpresentation of the glycan on a protein. These
contributions are summarized in Fig. 6.
The binding of the CRD of MGL to orosomucoid
variants with increasing numbers of glycans reveals
that themonomeric CRDhas up to 2.7-fold increased
affinity for orosomucoid variants with increasing
numbers of glycans, as the KI,Gal/KI,ligand value
normalized to the number of terminal galactose
residues increases from 101 to 270 on going from one
to five glycans on the orosomucoid (Table 3). This
increase could mean that, in addition to secondary
interactions with branches within a glycan and with
the protein to which the glycan is bound, the CRD
can interact with other oligosaccharides attached to
the glycoprotein ligand. However, it may also reflect
the potential of some variants occasionally to bridge
between two monomers immobilized on the poly-
styrene surface. Variation in the affinities of MGL for
different variants of orosomucoid with two attached
glycans probably reflects differences in the spacing
of the glycans, but in the absence of more structural
information about how the glycans project from the
surface of the protein, it is difficult to discern a
specific pattern correlating spacing with enhanced
affinity.
Effect of MGL oligomerization on binding to
glycoprotein ligands
With knowledge of the effect of glycan branching
and presentation on the affinity of individual CRDs
for their ligands, it is possible to use the engineered
glycoproteins to investigate the effect of receptor
oligomerization on affinity for multivalent ligands.
Binding of the singly glycosylated variants of
orosomucoid to the trimeric extracellular domain
of MGL does not differ significantly from binding to
the monomeric CRD, indicating that binding of
multiple CRDs in the trimer to branches of a single
glycan on the glycoprotein is not a factor in
enhanced glycoprotein ligand binding (Table 3
and Fig. 6). The 1.6-fold tighter binding of the free
tri-antennary glycopeptide from asialofetuin to the
trimer compared to the monomer (Table 1) might
reflect accessibility not present in the protein-bound
oligosaccharide.
Binding of multiple glycans on a target ligand to
multiple CRDs in a receptor oligomer represents one
form of affinity enhancement through multivalency
that has been observed for soluble lectins (Fig. 1g).
As expected for this effect, the affinity of the trimeric
extracellular domain of MGL shows a further
enhancement compared to the monomeric CRD
when binding to orosomucoid variants with two or
more glycans (Fig. 6). However, the magnitude of
this enhancement is only about twofold, compared
to much higher levels of enhancement observed for
other glycan-binding proteins, such as pentameric
bacterial toxins.5 The key difference in this case is
that the natural targets for such toxins are mem-
branes with multiple, widely spaced glycolipid
ligands rather than simple soluble glycoproteins
with relatively closely spaced glycans. Solublemultivalent ligands designed to interact with the
toxins consist of multiple target glycans arrays on a
scaffold that positions them at sufficient distances to
interact with the multiple binding sites in the toxin
oligomer.
Further affinity enhancements in native
asialo-orosomucoid
Comparison of the binding of MGL to asialo-
orosomucoid derived from human blood with the
protein bearing five glycans expressed in Chinese
hamster ovary cells reveals that even with five
glycans, the expressed protein has a lower affinity
for both receptors than the natural protein (Table
3). As shown in Table 2, the orosomucoid from
Chinese hamster ovary cells has a smaller fraction
of tetra-antennary and a larger fraction of bi-
antennary glycans compared to serum-derived
asialo-orosomucoid,33 but the comparisons de-
scribed earlier suggest that the increased degree
of branching has only a modest effect on the affinity
of binding to a CRD. Thus, it is likely that this
difference reflects the presence of additional termi-
nal glycan elaborations found on the natural
protein but not synthesized in the cultured cells.
For example, addition of outer arm fucose residues
is known to be a common modification of serum
orosomucoid,35 generating the Lewisx epitope,
which gives strong signals in glycan array analysis
of MGL.30 Such structures are not found on the
expressed proteins. A difference in binding of the
natural and expressed proteins is observed for both
the monomeric CRD and the trimeric extracellular
domain, which is consistent with the suggestion
that the difference lies in the interaction of
individual CRDs with individual branching and
terminal structures.Discussion
The observation that comparable affinity enhance-
ments for binding of single protein-bound glycans to
monomeric CRDs are observed for receptors as
distantly related as DC-SIGN and MGL, and the
fact that the enhancement is not unique to a glycan at
a single site on a glycoprotein suggests a relatively
nonspecific effect. At least two mechanisms can be
suggested: low-specificity interactions between the
surfaces of the CRD and the protein portion of the
glycoprotein ligand, or restriction in the conforma-
tion of the glycans when they are attached to
glycoprotein. As an illustration of the first mecha-
nism, binding of the C-type CRD of E-selectin to P-
selectin glycoprotein ligand 1 is enhanced by inter-
action with sulfated tyrosine residues in a region of
the protein adjacent to the glycan that binds in the
primary binding site of the CRD.36 Mutagenesis
studies suggest that in this case, the negative charges
on the sulfated tyrosine residues provide a relatively
nonspecific interaction that adds to the overall
affinity for the glycoprotein ligand. There is also
693High Affinity Glycoprotein–Receptor Bindingsubstantial evidence that the flexibility of glycans is
restricted when they are attached to proteins, which
would lead to a decreased entropy penalty and
hence increased affinity of a CRD for glycans
presented in preferred conformations on glycopro-
tein backbones. Examples of glycoproteins in which
the interaction of glycans with the protein surface
have been examined in molecular detail include
CD2,37 the α subunit of human chorionic gona-
dotropin,38 ribonuclease B,39 and viral envelope
glycoproteins including the Epstein-Barr virus
major envelope glycoprotein.40 Interactions between
the glycan and protein portion of the glycoprotein
typically occur between the first and second GlcNAc
residues in the core and can result in the glycan lying
parallel with the protein surface. Although the
terminal residues of the glycan would remain
accessible for lectin binding, the overall conforma-
tional space accessible to these glycans is substan-
tially reduced.
The affinity measurements reported here were
made in assay formats that allow us to dissect out
effects associated with interactions of individual
oligosaccharides and glycoproteins with individual
CRDs and receptor oligomers. Combining the
enhancements for binding of glycoproteins to
MGL, as summarized in Table 3 and Fig. 6, results
in an overall enhancement of nearly 3000-fold for
binding of the natural, multiply glycosylated asialo-
orosomucoid to the receptor trimer, corresponding
to a sub-micromolar affinity. Multivalent interaction
between glycoproteins and oligomeric receptors
makes only a very modest contribution to this total
enhancement.
When comparing the increase in affinity observed
in these studies with enhancements of up to 106-
fold that have been reported for oligosaccharide
binding to solubilized receptors or receptors on cell
surfaces,7,41 and for soluble multivalent lectins such
as the galectins,42 it is important to note that in the
work presented here the interactions have been
assessed in assays that segregate out the effects of
two-and three-dimensional lattice formation (Fig. 1h
and i). Three-dimensional lattice formation is well
documented for the interactions of galectins with
multivalent ligands,7,8,43,44 but such three-dimen-
sional lattice formation, which probably contributes
to high-affinity interaction in assays using solubi-
lized membrane receptors, would not reflect a
geometrically plausible arrangement for these recep-
tors in their natural membrane environment. Two-
dimensional lattice formation in membranes is a
much more plausible explanation for the further
enhancements observed in experiments on hepato-
cytes with natural or synthetic oligosaccharides or
glycopeptides.7,41,45 Such enhancements have been
observed with free oligosaccharides, corresponding
to bridging of the type illustrated in the left-hand
portion of Fig. 1h. However, the geometrical
arrangement of binding sites in receptor oligomers
and the extended interactions of the CRDs with
oligosaccharide ligands might interfere with such
interactions. In addition, free oligosaccharide orglycopeptide ligands have been observed in extend-
ed conformations when complexed with multivalent
lectins in three-dimensional lattices.43,46 These struc-
tures suggest that the affinity for single glycans could
be overestimated in such studies compared to what
would be achieved for glycans that are attached to
glycoproteins and are thus constrained in conforma-
tion. In the natural situation, two-dimensional lattice
formation might be more likely to result from
binding of multiple receptor oligomers to multiple
glycans on a glycoprotein, as shown at the right in
Fig. 1h. The possibility of pattern matching between
fixed arrays of CRDs and the terminal sugars on
oligosaccharides, either in receptor oligomers or in
cell surface lattices has been suggested.47 However,
experiments with DC-SIGN binding to oligosacchar-
ides on a membrane surface indicate that, in some
cases, receptor mobility and flexibility in the posi-
tioning of CRDs might be necessary for the receptors
to adapt to the disposition of glycans on surfaces.15Material and Methods
Expression of fragments from glycan-binding receptor
Expression of the extracellular domain and CRD from
DC-SIGN13 and CRDs from rat MGL and RHL-112
followed published procedures. The extracellular do-
main of DC-SIGN was further purified on a Mono-Q
anion-exchange column.13 The extracellular domains of
MGL (NCBI accession number P49301) from residue 59 to
the C-terminus were expressed in an analogous T7
promoter system with an extra alanine residue appended
at the N-terminus.
Glycoproteins and glycopeptide preparation
Bovine fetuin (Sigma) and soybean agglutinin, prepared
by affinity chromatography,48 were dissolved to 100 mg in
5 ml of 1% (w/v) ammonium bicarbonate and digested for
20 h at 37 °C with 5 mg of subtilisin (Sigma), resulting in
short peptide fragments. Digested material was treated
with 2 mM phenylmethylsulphonyl fluoride (Sigma;
prepared at 30 mg/ml in ethanol) and lyophilized before
being dissolved in 0.5ml of 5% (v/v) acetic acid and loaded
onto a Sephadex G-50 column (7 mm×500 mm) run in 1%
acetic acid.49 Sugar-containing fractions (0.5 ml) were
pooled. Glycopeptides were treated with neuraminidase
and repurified by passage through the Sephadex G-50
column.
Production of orosomucoid variants
A cDNA for orosomucoid was cloned from a human
liver cDNA library (ClonTech) using forward primer:
AACCTCCTGGTCTCAGTATGGCGCTGTCCTGGG and
reverse primer: TTCTAGTGATGGTGATGGTGATGT-
CCGGATTCCCCCTCCTCCTGTTTCCTCTC (Invitrogen)
which created a His6 tag at the C-terminal end of the
encoded protein. Glycosylation site mutations were
created by inserting double-stranded synthetic oligonu-
cleotides that included the desired mutations between
appropriate restriction sites in the cDNA. In each case, the
AAC or AAT codon for the asparagine residue of the N-
694 High Affinity Glycoprotein–Receptor Bindingglycosylation sequence (Asn-X-Ser/Thr) was mutated to
the glutamine codon CAG. Mutations were verified by
DNA sequencing, and the wild type and modified cDNAs
were transferred into the eukaryotic expression vector
pED.50 The dihydrofolate reductase-deficient Chinese
hamster ovary (CHO) cell line DXB11 was transfected
with mutant constructs using the calcium phosphate
method.51 Following selection for two weeks in MEM
alpha medium without nucleosides supplemented with
10% (v/v) dialyzed fetal calf serum, colonies were
combined. Protein expression was amplified by passaging
cells into medium containing methotrexate at 0.02 μM,
0.1 μM and 0.5 μM over a period of several weeks.
For production of protein, cells were grown to
confluence in selection medium and transferred to
serum-free medium: CHO-S-SFM II (Invitrogen) supple-
mented with 50 mM Hepes, pH 7.55, 4 μM CaCl2 and
0.5 μM methotrexate. Medium was harvested every two
days for eight days, pooled, made to 0.5 M NaCl, 25 mM
Tris–HCl, pH 7.8, 20 mM imidazole, centrifuged at
10,000 g for 15 min and loaded onto a 2 ml nickel-NTA-
Sepharose column (Amersham Biosciences) equilibrated
with N1 buffer (0.5 MNaCl, 25 mMTris–HCl, pH 7.8). The
column was washed with 8 ml of N1 buffer containing
20 mM imidazole and eluted with 8×1 ml of N1 buffer
containing 100 mM imidazole. Fractions were analyzed by
SDS-PAGE and those containing protein were pooled,
diluted fivefold in N1 buffer and re-loaded onto a 2 ml Ni-
NTA-Sepharose column. The column was eluted with
8×1 ml of N1 buffer containing 200 mM imidazole to
concentrate the protein. The final protein-containing
fractions were dialyzed against 50 mM sodium citrate,
pH 6.0 and incubated with Clostridium perfringens neur-
aminidase (New England Biolabs) at 37 °C overnight. In
order to remove the neuraminidase, fractions were made
up to 0.5 M NaCl, 25 mM Tris–HCl, pH 7.8, 20 mM
imidazole and loaded again onto a 2-ml Ni-NTA-
Sepharose column and eluted with 8×1 ml of N1 buffer
containing 200 mM imidazole. Protein yields were 1 ∼
2 mg of desialylated variant orosomucoid per 100 ml of
collected cell culture medium.
Surface plasmon resonance studies
Analysis was done with a BiaCore 3000 instrument.
CM5 sensor chips (Pharmacia Biosensor) were activated
with N-hydroxysuccinimide and 1-ethyl-3-(3-dimethyla-
minopropyl) carbodiimide following the supplier's proto-
cols. Coupling was performed for 10 min at a flow rate of
10 μl/min with 50 μg/ml ligand in 10 M sodium acetate,
pH 5.0 for proteins and pH 4.0 for glycopeptide, followed
by blocking with 1 M ethanolamine–HCl. All analysis was
done in running buffer (10 mM Hepes, 150 mM NaCl,
5 mMCaCl2 with 0.005% (v/v) P20 (surfactant), pH 7.4), at
25 °C and a flow rate of 10 μl/min. Sensor chip surfaces
were regenerated with EDTA-containing regeneration
buffer. SigmaPlot was used to fit data to an equation for
simple, saturable binding with a dissociation constant KD
superimposed on a linearly increasing background of non-
specific binding.12
Competition binding assays
Competition assays, in which receptor fragments were
immobilized on polystyrene wells (Immulon 4 HBX
from Thermo Labsystems), were done as described,
using 125I-labeled Gal-BSA and 125I-labeled Man-BSA as
a reporter ligands.12,13 In each experiment, duplicatetitrations were performed and the average values for
each concentration were used in a nonlinear, least-squares
fitting program (SigmaPlot) to determine the concentra-
tions of competing ligand required for 50% inhibition of
reporter ligand binding (KI).12 The data are presented as
average±standard deviation for at least three independent
experiments.Glycan analysis
Reduction and carboxymethylation were done as
described.52 Samples were reduced at 37 °C for 1.5 h in
50 mM Tris–HCl buffer, pH 8.5, containing 2 mg/ml
dithiothreitol, and carboxymethylated by reaction with
12 mg/ml iodoacetic acid at room temperature for 1 h.
Carboxymethylation was terminated by dialysis against
50 mM ammonium bicarbonate, pH 8.5, at 4 °C for 36 h,
followed by lyophilization. Samples were incubated with
trypsin (Sigma) at a 50:1 (w/w) ratio in 50 mM ammo-
nium bicarbonate, pH 8.5, for 16 h at 37 °C. The digestion
was terminated by incubation at 100 °C for 3 min,
followed by C18 Sep-Pak chromatography (Waters).
Bound peptides were eluted with either 20% (v/v) or
40% (v/v) propanol in 5% (v/v) aqueous acetic acid,
pooled and lyophilized. Digestion with peptide N-
glycosidase F (Roche Molecular Biochemicals) was done
in ammonium bicarbonate (50 mM, pH 8.5) for 16 h at
37 °C using 3 U of enzyme. The reaction was terminated
by lyophilization and the released N-glycans were
separated from peptides and O-glycopeptides by passage
through a Sep-Pak C18 (Waters) column and permethy-
lated using the NaOH procedure.52 Matrix-assisted laser
desorption/ionization time-of-flight (MALDI-TOF) data
were acquired on a Voyager-DE sSTR mass spectrometer
(PerSeptive Biosystems) in the reflectron mode with
delayed extraction. Permethylated samples were dis-
solved in 10 μl of 80% (v/v) methanol in water, and 1 μl
of dissolved sample was premixed with 1 μl of matrix
(10 mg/ml 2,5-dihydroxybenzoic acid in 80% (v/v)
aqueous methanol) before loading onto a metal plate.
The matrix-assisted laser desorption-ionization time-of-
flight tandem mass spectrometry experiments were done
with a 4800 Proteomics Analyzer (Applied Biosystems)
operated in reflectron positive ion mode.Other analytical procedures
SDS-PAGE was done by the method of Laemmli.53
Sugar-containing fractions were assayed by the anthrone
assay,54 and protein was assayed by the method of
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